[Influence of long-term beta adrenergic therapy on the HPL blood level and the total excretion of estrogens].
Pregnant women with imminent miscarriage were treated with Partusisten and/or Dilatol for tocolysis beginning in the 29. week of pregnancy. During treatment the mean urinary excretion of total oestrogens (n = 35; p less than 0,01 in 36th week of pregnancy and later) and the mean plasma level of HPL increased (n = 8; p less than 0,01 in 33., 34. and 35. week of pregnancy). These changes have to be concidered in judging the fetoplacental unit or the function of placenta.
D000033:Abortion, Threatened / Q000517:prevention & control; D004967:Estrogens / Q000652:urine*; D004983:Ethanolamines / Q000494:pharmacology*; D005260:Female; D005280:Fenoterol / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D010928:Placental Lactogen / Q000097:blood*; D011247:Pregnancy; D013997:Time Factors
D004967:Estrogens; D004983:Ethanolamines; D005280:Fenoterol; D010928:Placental Lactogen
Einfluss der Beta-Adrenergika-Langzeittherapie auf den HPL-Blutspiegel und die Gesamt-Ostrogenausscheidung.